AI assistant
Microbot Medical Inc. — Director's Dealing 2016
Apr 19, 2016
33819_dirs_2016-04-18_fb770d4f-b9d7-4946-a791-50894e4fc4b1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2016-03-15
Reporting Person: SCHIFFMAN GREGORY T (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-15 | Common Stock | A | 720000 | $0.00 | Acquired | 1599717 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 21597 | Indirect |
Footnotes
F1: Restricted stock units with performance based vesting set by the issuer's Board of Directors and tied to the timely and successful conduct and completion of the issuer's Phase II clinical study in spinal cord injury.
F2: Includes (1) 175,000 restricted stock units, with 87,500 of these vesting on each of January 1, 2017 and January 1, 2018; and (2) 118,666 restricted stock units, with 59,333 of these vesting on each of January 8, 2017 and January 8, 2018; and (3) 970,000 restricted stock units with performance based vesting.
F3: Shares held in 401(k) account in accordance with issuer's employer-match policies.